Technology has become so ubiquitous that we see modernized and digitized versions of most aspects of our lives everywhere we look. The drug development department has fallen behind in utilizing technology to make the process more effective and cost-efficient. But it is slowly catching up with newer technologies in the medical industry, like smart health monitors, telehealthcare, remote health examination kits, and dissolution apparatus.
Albeit late in the game, the healthcare industry is catching up steadily, and the future looks promising. These technologies are revolutionizing drug and therapy development. They allow the faster and more accurate collection of information that saves lives.
Another significant aspect of drug development that is crucial in healthcare is the clinical trials of drugs. These trials that experts implement to collect data can help experts evaluate the safety and effectiveness of drugs. Unfortunately, some processes that experts are still using to collect data are archaic, even if there have been better technologies to make this process better, faster, and safer. That was the case until Continuomics came and became a game-changer in the field of drug trial and development.
Artificial Intelligence-operated Healthcare Technologies
Hypertension, asthma, and diabetes are chronic conditions that A.I.-based technologies are already managing. Besides these, many consumers also use these smart devices to help them lose weight or manage it, help their productivity, and get better sleep.
As professionals are already utilizing these technologies to provide healthcare, the future of using such technological advancements for drug development is also nearing. These technologies are called Continuomics. It is an application of digital technologies that would allow to more accurately and efficiently gather data from drug trial participants and analyze them with better results than any trained human can provide, which could potentially change healthcare for the better. If these kinds of technology-dependent drug trials persist, virtual clinical trials will become possible soon.
The Present Case Of Drug Trials And Development
As the modernization of healthcare continues to grow, researchers will soon be able to measure data of participants of clinical trials of drugs on a daily basis without any disruptions to their everyday lives. With Continuomics, participants who have the device remotely connected to the researchers’ database, clinicians would be able to accurately assess their health and how their bodies respond to the drug. These technologies would lessen the need for the participants to meet doctors and researchers, which is a significant improvement in the process.
Clinicians will better understand each participant’s response to potential drug therapy, and the results are in real-time. Before Continuomics, each participant would have to visit clinicians for a check-up at least once a week during the duration of the trial. But it wasn’t enough to accurately assess the drug’s impacts because clinicians have to test participants as regularly as possible. But because each participant has a life outside of these trials, some would eventually drop out.
Fortunately, these setbacks to drug trials are slowly becoming a thing of the past. With Continuomics, researchers and clinicians can detect any other non-desirable and adverse effects that a new drug does to a participant. These effects could be an allergic reaction, overdoses, drug reactions, and more.
Important factors for drug trials like participants’ adherence in taking the treatments and the effect of the drug on the participants’ daily activities and sleep quality will also be measured and recorded in real-time. These data will help drug trials be concluded sooner as the costs and value of drug compounds are better analyzed and understood.
The Future Of Drug Trials And Development
Without a doubt, Continuomics is slowly revolutionizing healthcare and changing drug trials. As the application continues to become more widely available, more accurate results are gathered for a shorter time are required from a lesser number of participants, which lowers the costs of the research that can still produce more efficient results. These milestones could make life-saving drugs, treatments, and therapies available to the market and the public faster.
The Game-changing Continuomics
Continuomics utilized for drug clinical trials is only the tip of the iceberg as these technologies could also be used to better grasp each individual’s overall health and possibly predict the risk they have in getting certain diseases, alongside their responses to specific therapies based on their genetic information.
The modernization of healthcare is moving at a snail’s pace. Still, in the near future, when the healthcare industry finally utilizes technologies like Continuomics, many diseases and illnesses will be treated better or could even be prevented.